OC.56 Safety and early efficacy of rapcabtagene autoleucel, an autologous CD19-directed chimeric antigen receptor T-cell therapy, in severe refractory diffuse cutaneous systemic sclerosis
D Khanna, Christopher P Denton, M Kuwana, Francesco Del Galdo et autres
us, gb, jp, nl, sg, it, au, fr, il, ch, es, in (code pays fourni par la source)